Circulating angiogenic proteins in trisomy 13

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 1, 2006, Pages 239-245

  Bdolah, Yuval ^a   Palomaki, Glenn E ^b,c   Yaron, Yuval ^d   Bdolah Abram, Tali ^e   Goldman, Marlene ^a   Levine, Richard J ^f   Sachs, Benjamin P ^a   Haddow, James E ^b,c   Karumanchi, S Ananth ^a,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b FOUNDATION FOR BLOOD RESEARCH   (United States)

^c WOMEN AND INFANTS HOSPITAL   (United States)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e Department of Health and Human Services ^*

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis factor; Placental growth factor; Preeclampsia; Soluble fms like tyrosine kinase 1 (sFlt 1); Trisomy 13

Indexed keywords

ANGIOGENIC PROTEIN; ISOENZYME; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE;

ARTICLE; BLOOD SAMPLING; CIRCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIRST TRIMESTER PREGNANCY; HUMAN; KARYOTYPE; MATERNAL AGE; MATERNAL SERUM; PARITY; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCREENING; SECOND TRIMESTER PREGNANCY; SOLUBILITY; STATISTICAL SIGNIFICANCE; TIME; TRISOMY 13; TRISOMY 18; TRISOMY 21;

ANGIOGENIC PROTEINS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; SINGLE-BLIND METHOD; TRISOMY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 29544438129     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.06.031     Document Type: Article

References (42)

1. J.J. Walker Pre-eclampsia Lancet 356 2000 1260 1265
2. B.M. Sibai, S. Caritis, and J. Hauth What we have learned about preeclampsia Semin Perinatol 27 2003 239 246
3. M. Chen, G.P. Yeh, J.C. Shih, and B.T. Wang Trisomy 13 mosaicism: study of serial cytogenetic changes in a case from early pregnancy to infancy Prenat Diagn 24 2004 137 143
4. M. Nagaishi, T. Yamamoto, K. Iinuma, K. Shimomura, S.A. Berend, and J. Knops Chromosome abnormalities identified in 347 spontaneous abortions collected in Japan J Obstet Gynaecol Res 30 2004 237 241
5. S.A. Rasmussen, L.Y. Wong, Q. Yang, K.M. May, and J.M. Friedman Population-based analyses of mortality in trisomy 13 and trisomy 18 Pediatrics 111 2003 777 784
6. J.F. Tuohy, and D.K. James Pre-eclampsia and trisomy 13 BJOG 99 1992 891 894
7. C. Bower, F. Stanley, and B.N. Walters Pre-eclampsia and trisomy 13 Lancet 2 1987 1032
8. P.A. Boyd, R.H. Lindenbaum, and C. Redman Pre-eclampsia and trisomy 13: a possible association Lancet 2 1987 425 427
9. P.A. Boyd, E.J. Maher, R.H. Lindenbaum, A.M. Hoogwerf, C. Redman, and M. Crocker Maternal 3;13 chromosome insertion, with severe pre-eclampsia Clin Genet 47 1995 17 21
10. J. Evers, J. Seelen, and G. Blankenborg Severe toxemia, hydramnios and trisomy 13-15 Ned Tijdschr Verloskd Gynaecol 67 1967 395 397
11. R.F. Feinberg, H.J. Kliman, and A.W. Cohen Preeclampsia, trisomy 13, and the placental bed Obstet Gynecol 78 1991 505 508
12. R. Heydanus, P. Defoort, and M. Dhont Pre-eclampsia and trisomy 13 Eur J Obstet Gynecol Reprod Biol 60 1995 201 202
13. B.W. Pedersen, and A. Gronlund [Severe pre-eclampsia and fetal trisomy 13 in a multiparous woman] Ugeskr Laeger 165 2003 2108 2109
14. J.G. Thornton, P. O'Donovan, R. Stigter, and J. Williams Pre-eclampsia and trisomy 13 Lancet 2 1987 794
15. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
16. V. Tsatsaris, F. Goffin, C. Munaut, J.F. Brichant, M.R. Pignon, and A. Noel Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 2003 5555 5563
17. H. Sugimoto, Y. Hamano, D. Charytan, D. Cosgrove, M. Kieran, and A. Sudhaker Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria J Biol Chem 278 2003 12605 12608
18. K. Koga, Y. Osuga, O. Yoshino, Y. Hirota, X. Ruimeng, and T. Hirata Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia J Clin Endocrinol Metab 88 2003 2348 2351
19. T. Chaiworapongsa, R. Romero, J. Espinoza, E. Bujold, Y. Mee Kim, and L.F. Goncalves Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: young investigator award Am J Obstet Gynecol 190 2004 1541 1550
20. A. Hertig, N. Berkane, G. Lefevre, K. Toumi, H.P. Marti, and J. Capeau Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia Clin Chem 50 2004 1702 1703
21. R.J. Levine, S.E. Maynard, C. Qian, K.H. Lim, L.J. England, and K.F. Yu Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
22. R. Thadhani, W.P. Mutter, M. Wolf, R.J. Levine, R.N. Taylor, and V.P. Sukhatme First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia J Clin Endocrinol Metab 89 2004 770 775
23. R.J. Levine, R. Thadhani, C. Qian, C. Lam, K.H. Lim, and K.F. Yu Urinary placental growth factor and risk of preeclampsia JAMA 293 2005 77 85
24. Y. Bdolah, V.P. Sukhatme, and S.A. Karumanchi Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights Semin Nephrol 24 2004 548 556
25. S.A. Karumanchi, and Y. Bdolah Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question Endocrinology 145 2004 4835 4837
26. W.J. Conover Practical nonparametric statistics 1980 Wiley & Sons New York
27. K. Spencer, A.W. Liao, C.Y. Ong, L. Geerts, and K.H. Nicolaides First trimester maternal serum placenta growth factor (PIGF) concentrations in pregnancies with fetal trisomy 21 or trisomy 18 Prenat Diagn 21 2001 718 722
28. Y.N. Su, J.J. Hsu, C.N. Lee, W.F. Cheng, C.C. Kung, and F.J. Hsieh Raised maternal serum placenta growth factor concentration during the second trimester is associated with Down syndrome Prenat Diagn 22 2002 8 12
29. F. Debieve, A. Moiset, K. Thomas, S. Pampfer, and C. Hubinont Vascular endothelial growth factor and placenta growth factor concentrations in Down's syndrome and control pregnancies Mol Hum Reprod 7 2001 765 770
30. G.M. Lambert-Messerlian, and J.A. Canick Placenta growth factor levels in second-trimester maternal serum in Down syndrome pregnancy and in the prediction of preeclampsia Prenat Diagn 24 2004 876 880
31. R. Arngrimsson, S. Sigurard ttir, M.L. Frigge, R.I. Bjarnadttir, T. Jonsson, and H. Stefansson A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13 Hum Mol Genet 8 1999 1799 1805
32. A.M. Lachmeijer, R. Arngrimsson, E.J. Bastiaans, M.L. Frigge, G. Pals, and S. Sigurdardottir A genome-wide scan for preeclampsia in the Netherlands Eur J Hum Genet 9 2001 758 764
33. J. Laasanen, M. Hiltunen, E.L. Romppanen, K. Punnonen, A. Mannermaa, and S. Heinonen Microsatellite marker association at chromosome region 2p13 in Finnish patients with preeclampsia and obstetric cholestasis suggests a common risk locus Eur J Hum Genet 11 2003 232 236
34. A.M. Lachmeijer, G.A. Dekker, G. Pals, J.G. Aarnoudse, L.P. ten Kate, and R. Arngrimsson Searching for preeclampsia genes: the current position Eur J Obstet Gynecol Reprod Biol 105 2002 94 113
35. J.M. Roberts, and D.W. Cooper Pathogenesis and genetics of pre-eclampsia Lancet 357 2001 53 56
36. T. Woodage, J.C. Venter, and S. Broder Application of the human genome to obstetrics and gynecology Clin Obstet Gynecol 45 2002 711 732
37. E.K. Moses, J.A. Lade, G. Guo, A.N. Wilton, M. Grehan, and M. Freed A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2 Am J Hum Genet 67 2000 1581 1585
38. L.C. Chesley, J.E. Annitto, and R.A. Cosgrove The familial factor in toxemia of pregnancy Obstet Gynecol 32 1968 303 311
39. K. Ward, A. Hata, X. Jeunemaitre, C. Helin, L. Nelson, and C. Namikawa A molecular variant of angiotensinogen associated with preeclampsia Nat Genet 4 1993 59 61
40. R. Arngrimsson, S. Purandare, M. Connor, J.J. Walker, S. Bjornsson, and F. Soubrier Angiotensinogen: A candidate gene involved in preeclampsia? Nat Genet 4 1993 114 115
41. R. Bunting, and J. Leitch Buphthalmos in trisomy 13 Eye 19 2005 487 488
42. S.R. Phadke, and S.J. Patil Partial trisomy 13 with features similar to c syndrome Indian J Pediatr 41 2004 614 617